See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 2, 2003

Alzheimer's Disease Migraine and Cluster Headaches Acne

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Alzheimer's Disease

A study to assess the efficacy of a currently marketed prescription drug approved for the treatment of mild to moderate Alzheimer's disease. Volunteers between the ages of 50 and 90 who have a diagnosis of probable Alzheimer's disease, are in generally good health, and have a caregiver who will participate in the study may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat11.html.

-----

Migraine and Cluster Headaches

A research study investigating an oral medication already approved for the treatment of migraine pain in adults to determine whether it reduces migraine pain in adolescents. Volunteers between 12 and 17 years old who have at least a one-year history of migraine headaches and have an average of 1 to 6 moderate to severe migraine attacks per month may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat100.html.

-----

Acne

A research study to test the effectiveness of an investigational medication for the treatment of acne. Female volunteers ages 14-45 who have moderate facial acne may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat1.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.